BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1225309)

  • 21. Immunological considerations in hodgkin's disease.
    Johnson AG
    Radiol Clin North Am; 1968 Apr; 6(1):41-4. PubMed ID: 5652934
    [No Abstract]   [Full Text] [Related]  

  • 22. [Graft of fetal thymus in Hodgkin's disease and in other malignant neoplasms].
    Ringenbach MG
    Bord Med; 1970 Apr; 3(4):1009-10 passim. PubMed ID: 5422389
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunological data in the clinical evaluation of Hodgkin's diseases].
    Burchardt K
    Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal lymphocyte responses in residents of a town with a cluster of Hodgkin's disease.
    Plouffe JF; Silva J; Schwartz RS; Callen JP; Kane P; Murphy LA; Goldstein IJ; Fekety R
    Clin Exp Immunol; 1979 Feb; 35(2):163-70. PubMed ID: 436334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunological competence in Hodgkin's disease].
    Lang JM
    Pathol Biol (Paris); 1973 Mar; 21(3):285-97. PubMed ID: 4145143
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunohistochemical comparative investigations of lymphatic tissue in reactive processes, myasthenic thymuses and Hodgkin's disease.
    Zółtowska A
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):15-22. PubMed ID: 8744679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical condition of patients with Hodgkin's disease and the mitotic index in white blood cell cultures after stimulation with phytohemagglutinin.
    Pluzańska A
    Pol Med J; 1970; 9(4):841-6. PubMed ID: 5477491
    [No Abstract]   [Full Text] [Related]  

  • 30. BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective.
    Cooney JP; Stiff PJ; Toor AA; Parthasarathy M
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):177-82. PubMed ID: 12652468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The immune response in Hodgkin's disease].
    Schneider M; Schwarzenberg L; Amiel JL; Hayat M; Mascaro G; Otmezguine Y; Mathé G
    Presse Med (1893); 1970 Oct; 78(41):1769-74. PubMed ID: 4097017
    [No Abstract]   [Full Text] [Related]  

  • 32. Nodular lymphocyte predominant Hodgkin's lymphoma.
    Siddiqui N; Al-Diab AI
    Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological status of nude mice engrafted with allogeneic or syngeneic thymuses.
    Furukawa F; Ikehara S; Good RA; Nakamura T; Inoue S; Tanaka H; Imamura S; Hamashima Y
    Thymus; 1988; 12(1):11-26. PubMed ID: 2977452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International symposium on Hodgkin's disease. Session I. Epidemiology and etiology. Part 3. Immunology. Introduction.
    Good RA
    Natl Cancer Inst Monogr; 1973 May; 36():93-4. PubMed ID: 4582999
    [No Abstract]   [Full Text] [Related]  

  • 36. Hodgkin's disease: response of lymphocytes to PHA.
    Sforza MB; De Somoza N; Morgenfeld CM
    Sangre (Barc); 1971; 16(3):300-4. PubMed ID: 5120513
    [No Abstract]   [Full Text] [Related]  

  • 37. [Peripheral blood lymphocyte subpopulations in Hodgkin's disease].
    Burchardt K
    Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1283-5. PubMed ID: 1080566
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of Hodgkin's malignant lymphoma in children and adolescents by immunomodulation with a dialysate of human leukocytes].
    Mydlil J
    Cesk Pediatr; 1991 May; 46(5):266-9. PubMed ID: 1893465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lymphocytes and Hodgkin's disease. Study of crossing and blastogenesis].
    Cavallero P; Sartoris S; Vergnano F
    Minerva Med; 1972 Sep; 63(60):3255-7. PubMed ID: 5054008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.